Common hormone could provide the answer to treating atrial fibrillation

November 5, 2020

Researchers from University of Montreal, Oxford University, Baylor College of Medicine and the University of Melbourne make potential game-changing discovery on calcitonin

New research published today in Nature shows that calcitonin, a well-recognized thyroid hormone that helps regulate bone mass and collagen production, is also produced by cells in the heart. This discovery could hold the key to developing new treatments for people with atrial fibrillation (AF), a common and quite problematic heart rhythm disorder.

learn more on the Institute website

Subscribe to our newsletter

Discover major projects made possible thanks to your donations and get tips to help you keep your heart healthy.

I’d like to receive the Montreal Heart Institute Foundation’s newsletter.

Please leave this field empty